Erector Spinae Block Versus PENG Block for Hip Replacement
PENGESP
1 other identifier
interventional
64
1 country
1
Brief Summary
THR (Total Hip Replacement) can be very painful and regional anesthesia is very effective in reducing postoperative pain. Erector Spinae Plane Block (ESPB) and PENG (pericapsular nerve group block) are alternative approaches to the hip sensitive nerve branches that resulted to be very promising for hip surgeries. However, no studies investigated the analgesic superiority of either PENG or ESPB. In our study the investigators compare PENG (with a lateral femoral cutaneous nerve block) and ESPB in terms of pain relief expressed as morphine consumption in the first 24 hours after primary THR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2023
CompletedFirst Posted
Study publicly available on registry
April 4, 2023
CompletedStudy Start
First participant enrolled
April 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 23, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 23, 2024
CompletedJuly 30, 2024
July 1, 2024
11 months
March 21, 2023
July 27, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
morphine consumption
milligrams of morphine by patient controlled analgesia intravenously
24 hours
Secondary Outcomes (4)
postoperative pain
48 hours
neuropathic pain
48 hours
postoperative complications
48 hours
chronic postoperative pain
3 months
Study Arms (2)
ERECTOR SPINAE PLANE BLOCK
ACTIVE COMPARATORultrasound guided block at L4
PERICAPSULARE NERVE GROUP AND LATERAL FEMORAL CUTANEOUS NERVE BLOCK
ACTIVE COMPARATORultrasound guided block below the ileo-psoas muscle tendon, above the ilio-pectineous eminence and ultrasound guided block of lateral femoral cutaneous nerve
Interventions
ULTRASOUND GUIDED - ROPIVACAINE 30 ml 0.5%
ULTRASOUND GUIDED - ROPIVACAINE 20 ml 0.5% + 10 ml 0.5%
bupivacaine 0.5% 2.2 ml
Eligibility Criteria
You may qualify if:
- primary total hip replacement
- informed consent
You may not qualify if:
- allergies to study drugs
- spinal anesthesia contraindicated
- kidney failure
- epilepsy, psychiatric disease, neurologic deficits
- revision surgery
- neuropathies in the lumbar area
- no informed consent
- pregnancy
- alcohol/opioid abuse
- emergency surgery/intensive care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aast Papa Giovanni Xxiii
Bergamo, 24127, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
March 21, 2023
First Posted
April 4, 2023
Study Start
April 13, 2023
Primary Completion
February 23, 2024
Study Completion
May 23, 2024
Last Updated
July 30, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share